当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析

特宝生物

(688278)

  

流通市值:291.63亿  总市值:291.63亿
流通股本:4.07亿   总股本:4.07亿

特宝生物(688278)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.66亿元,每股收益1.64元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益300925.99万元,未分配利润196433.14万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产378624.82万元,负债77698.83万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,479,547,947.461,510,615,117.77673,345,118.052,817,158,242.24
营业总成本1,721,216,914.121,025,083,005.41460,732,480.51,881,373,801.84
其他经营收益
营业利润781,386,853.42497,149,474.06219,964,882.27970,736,591.1
利润总额730,997,712.61476,272,103.72209,216,187.16931,026,564.03
净利润666,123,781.87427,894,111.21182,128,916.89827,602,233.89
每股收益
其他综合收益-81,743.32---
综合收益总额666,042,038.55427,894,111.21182,128,916.89827,602,233.89
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,234,609,651.071,869,679,350.531,920,029,729.81,827,090,165.08
非流动资产:
非流动资产合计1,551,638,564.121,339,687,744.031,259,093,906.581,223,324,670.5
资产总计3,786,248,215.193,209,367,094.563,179,123,636.383,050,414,835.58
流动负债:
流动负债合计581,467,931.59359,793,134.05345,501,840.59420,629,465.19
非流动负债:
非流动负债合计195,520,357.4594,187,098.6684,337,584.0376,469,078.64
负债合计776,988,289.04453,980,232.71429,839,424.62497,098,543.83
所有者权益(或股东权益):
归属于母公司股东权益合计3,009,259,926.152,755,386,861.852,749,284,211.762,553,316,291.75
股东权益合计3,009,259,926.152,755,386,861.852,749,284,211.762,553,316,291.75
负债和股东权益合计3,786,248,215.193,209,367,094.563,179,123,636.383,050,414,835.58
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,486,230,477.481,629,731,457.08821,319,493.662,575,362,843.73
经营活动现金流出小计2,015,112,270.781,269,186,044.61614,579,315.862,144,729,665.31
经营活动产生的现金流量净额471,118,206.7360,545,412.47206,740,177.8430,633,178.42
投资活动产生的现金流量:
投资活动现金流入小计1,047,660,067.17846,895,967.36581,354,103.53639,148,703.7
投资活动现金流出小计1,347,030,768.27793,678,266.44629,717,400.69947,765,507.5
投资活动产生的现金流量净额-299,370,701.153,217,700.92-48,363,297.16-308,616,803.8
筹资活动产生的现金流量:
筹资活动现金流入小计174,439,826.410,000,00010,000,000-
筹资活动现金流出小计258,357,766.87256,782,310.722,191,090.23173,016,998.14
筹资活动产生的现金流量净额-83,917,940.47-246,782,310.727,808,909.77-173,016,998.14
汇率变动对现金及现金等价物的影响-201,057.26170,763.6364,915.87-134,623.31
现金及现金等价物净增加额87,628,507.87167,151,566.3166,250,706.28-51,135,246.83
期末现金及现金等价物余额449,144,206.3528,667,264.73527,766,404.71361,515,698.43
补充资料:
现金及现金等价物的净增加额-167,151,566.3--51,135,246.83
最新报告期:2025-10-24
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中国银河孙怡,程培2.383.244.302025-10-24
东方证券伍云飞,赵博宇2.723.664.582025-08-29
东海证券杜永宏2.683.584.632025-08-25
西部证券李梦园2.683.554.672025-08-25
中国银河孙怡,程培2.763.604.672025-08-21
TOP↑